'Severe hemophilia' diaporamas de présentation

Alfonso Iorio

466 views • 33 slides

605 views • 32 slides

RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling

RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling. Hematological Disorders. Blood Components. Plasma: The liquid part of blood. All the blood cells are suspended in this liquid. Contains dissolved salts (electrolytes) and proteins

811 views • 30 slides

RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling

RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling. Hematological Disorders. Blood Components. Plasma: The liquid part of blood. All the blood cells are suspended in this liquid. Contains dissolved salts (electrolytes) and proteins

454 views • 30 slides

Hemophilia A

Hemophilia A. Constructed by Sarah Akiki. Overview of the disease.

437 views • 16 slides

Hemophilia A

Hemophilia A. Constructed by Sarah Akiki. Overview of the disease.

275 views • 16 slides

Hemophilia A

Hemophilia A. Constructed by Sarah Akiki. Overview of the disease.

169 views • 16 slides

HEMOPHILIA

HEMOPHILIA. MISHA MAZHAR 2k10-NUST-BS-V&I-54. OVERVIEW. An inherited bleeding disorder. Occurs in two forms. Hemophilia A. Hemophilia B. WHAT CAUSES HEMOPHILIA?. Mutations in F8 or F9 genes. Leads to lack of proteins made by these genes.

383 views • 11 slides

Hemophilia

Richard Paul Period 7 11/15/2011. Hemophilia. Symptoms. Hemophilia is characterized by the inability to clot. In mild cases, abnormal bleeding can occur after trauma or surgery.

450 views • 9 slides

Hemophilia

Hemophilia. BG. What is Hemophilia?. Genetic disease Inability for blood to clot properly, also the absence of anti-hemophilic factor. X-linked recessive (transmitted through female carriers)

246 views • 9 slides

LH / Q3012R Molecular Biology, Immunology, & Genetics of Coagulation Factors

LH / Q3012R Molecular Biology, Immunology, & Genetics of Coagulation Factors. Jay Lozier, M.D., Ph.D. Principal Investigator Report to the Blood Products Advisory Committee, September 29, 2005 on February 25, 2005 LH Site Visit. LH Regulatory Issues: Inhibitors to Factors VIII/IX.

225 views • 8 slides

Statement of the Problem

68 views • 2 slides

Statement of the Problem

63 views • 2 slides